We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LIF:NASDAQLife360, Inc. analysis

Data as of Oct 9, 2026 - not real-time

Latest price
$43.64
Risk: high
9/10High risk

Summary

Life360, Inc. is priced at $43.64 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 1.4%. With RSI at 54.3 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $39.31 and resistance around $45.10.
The shares look undervalued, trading on 25.4 times earnings below a sector average of 35.2. Consensus targets land 39.1% above where the shares trade now. Revenue is growing at 37.8% on a 25.7% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 41.1%, a beta of 2.36 and a maximum drawdown of 63.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 4/10 conviction over the longer horizon.

Top market events

  • Comparing Life360 and Droneshield: Profitability, momentum, and valuation — which ASX tech share comes out on top in...
  • Life360 stock may have dipped this week, but its operations are still firing on all cylinders.
  • Brit exercised vested options and liquidated them at $65 per share via a pre-established Rule 10b5-1 trading plan.

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 48.68
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 25.4 versus sector average of 35.2
  • Trading below the 200-day average of 48.68

Long term

> 3 years

Positive

Model confidence4/104 out of 10

Key factors

  • P/E of 25.4 versus sector average of 35.2
  • Analyst targets imply +39.1% versus the current price
  • Profit margin of 25.7% is healthy

Key metrics

Financial health

Revenue Growth37.80%
Profit Margin25.72%
P/E Ratio25.4
ROE30.06%
ROA0.45%
Debt/Equity50.80
P/B Ratio5.8
Op. Cash Flow$104.3M
Free Cash Flow$74.7M
Industry P/E35.2

Technical analysis

TrendBearish
RSI54.3
Support$39.31
Resistance$45.10
MA 20$41.33
MA 50$45.70
MA 200$48.68
MACDBullish
VolumeStable
Fear & Greed Index94.91

Valuation

Fair Value$31.26
Target Price$60.70
Upside/Downside39.09%
GradeUndervalued
TypeGrowth

Risk assessment

Beta2.36
Volatility41.08%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.